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A B S T R A C T  
Objective: To determine the frequency of measles and measles related 
complications in infants younger than 9 months of age.  
Methodology: A prospective observational study conducted in Department of 
Paediatrics Rawalpindi Medical University, Rawalpindi from January to 
December 2018. A pre-designed study tool was used to collect data. A total 
number of 298 cases of less than 9 months of age that presented to the Allied 
Hospitals of Rawalpindi Medical University with clinical diagnosis of measles 
were enrolled. The data was presented in the form of frequencies and 
percentages. 
Results: Out of 298 cases, majority 62% (n=185) were reported from Benazir 
Bhutto hospital, Rawalpindi, while 36.5% (n=109) and 1.6% (n=5) cases were 
reported from Holy Family Hospital and District Headquarter Teaching Hospital, 
Rawalpindi respectively. 57.4 % of the study population was male (n=171) while 
42.6 % was female (n=127). Mean age was found to be 6.62 month (SD ±2.13) 
with median age of 07 months. Age distribution for age groups 1-3 months, 4-6 
months and 7-9 months was found to be 11% (n=33), 31.3 % (n=93), and 57.7% 
(n=172) respectively.   
Conclusion: High numbers of infants under 9 months of age are affected by 
measles. Thirty per cent cases are complicated by pneumonia, gastroenteritis 
and otitis media.  
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Introduction 
Measles is the most transmissible infectious disease 
known to mankind, and is still one of the top causes of 
death in children worldwide.1Measles is normally 
transmitted by airborne respiratory droplets. Accelerated 
immunization activities have had a major impact on 
reducing measles deaths. Global measles deaths have 
decreased by 80% from an estimated 545 000 in 2000 to 
110 000 in 2017.2 
Pakistan is a country with a large (>185 million) mobile 
population with high birth rates and substantial spatial 
heterogeneity in measles vaccine coverage. 3 In the last 
few years, Pakistan has encountered many 
outbreaks/epidemics of measles. During 2018 outbreak 
32,135 cases of suspected measles were reported across 
the country with a major case load from Punjab and 
Sindh, and more than 5% of these patients were reported 
from district Rawalpindi. In 2012-13 measles epidemic, 
around 26,000 cases of suspected measles with 570 
deaths were reported by the WHO DEWS, during the 
period between January 2012 and Mid May 2013. 4 
Serious complications resulting from measles are more 
likely to develop in children who are immune-
compromised, malnourished or under the age of five 
years. Pneumonitis is the principal complication 
accounting for most measles-associated deaths.5The mean 
case fatality ratio for measles in low and middle income 
countries varied according to the study setting and was 
5.4% in community settings while it rose to 10.8% in 
hospital based studies.6In population with a high 
incidence of under nutrition and other infectious diseases, 
like in our country, case-fatality rate of measles is 
reported to be 3-6% and can reach up to 30% in complex 
emergencies.7Mortality in measles is primarily due to its 
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complications which include gastroenteritis, meningitis, 
pneumonia, and encephalitis. Measles related optic 
neuritis can lead to blindness. The risk of mortality and 
morbidity due to measles is greatest in children younger 
than 1 year of age and those who are unvaccinated.8 
World Health Organization (WHO) formulated the 
guidelines for measles vaccination in 1970 where it was 
recommended to give the first dose at 9 months of age in 
high-risk settings in the developing world. Measles 
Vaccine is safe, effective and inexpensive9 and has 
resulted in a dramatic decrease in measles associated 
mortality worldwide. Studies from Bangladesh10 and 
Haiti presented comparable results.11,19 
WHO has recommended measles vaccination even before 
9 months in endemic areas. To reduce measles related 
morbidity & mortality especially in the under 9 months 
age group, it is a prerequisite to determine the frequency 
of measles in our country affecting infants of this age. 
Keeping aside the failures and derelictions of routine EPI 
program and vaccination status of the infants, this study 
aims to determine the frequency of measles and measles 
related complications in infants younger than 9 months of 
age. 
Methodology 
A prospective observational study was carried out in 
Paediatric Department Rawalpindi medical university, 
Rawalpindi from January  to December 2018. Both the 
in-patients and outpatient cases attended at all teaching 
hospitals of Rawalpindi Medical University meeting the 
WHO case definition of measles were included in the 
study using purposeful/convenience sampling.  
WHO case definition for Measles was applied to any 
suspected case and patients fulfilling these criteria were 
included in this study. WHO clinical case definition of 
measles is “Any person in whom a clinician suspects 
measles infection, or any person with fever and 
maculopapular rash (i.e. non-vesicular) and cough, 
coryza (i.e. runny nose) or conjunctivitis (i.e. red eyes)”. 
Data was collected and entered in a predesigned 
questionnaire by the attending paediatrician at the time of 
admission and was updated during the hospital stay of the 
patient. Data was recorded in excel sheets andanalysed 
using SPSS version 20 for descriptive statistics.Only 
cases resident of district Rawalpindi were included in this 
study. 
Results  
A total number of 998 cases of age 1 months-12 years 
that presented to the Allied Hospitals of Rawalpindi 
Medical University with clinical diagnosis of measles 
were enrolled in a prospective observational study. Out of 
998 cases of measles, 298 (30 %) belonged to age group 
less than 9 months, constituting the study population for 
the present research. Majority of the cases 62% (n=185) 
were reported from Benazir Bhutto hospital, Rawalpindi, 
while 37% (n=109) and 1.6% (n=4) cases were reported 
from Holy Family Hospital and District Headquarter 
Teaching Hospital, Rawalpindi respectively.  
57.4 % cases were males (n=171) and 42.6 % cases were 
females n=127. Mean age was found to be 6.62 month 
(SD ±2.13) with median age of 07 months. Age 
distribution for age groups 1-3 months, 4-6 months and 7-
9 months was found to be 11% (n=33), 31.3 %(n=93), 
and 57.7% (n=172) respectively.  Exponential growth in 
no of cases was observed in respect of increasing age by 
5 months and above. 
The study observed a very high measles incident of 30%, 
complicated with pneumonia 39.6%, gastroenteritis 
23.5%, and otitis media 18.7%. 859 cases recovered 
completely while 08 cases died of pneumonia and 01 
expired due to measles encephalitis. 
 
Figure 1. Age in Months of Measles Patients 
Table II. Complications of Measles 
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Discussion 
Preventive measures are always better than curative 
actions, and immunization is the most commonly used 
measure for preventive health care. It reduces the 
hospitalization and treatment costs and has been adopted 
in order to avoid disease. It is also an indicator of parent’s 
motivation to ensure a child’s future welfare.  
The debate of being unprotected against measles and the 
possible plausible reasons for being unprotected as stated 
in regional literature due to scarcity of measles vaccine, 
gender disparity, spiritual beliefs and uncertain security 
conditions as reported for other vaccines is out of 
question. WHO EPI criteria to administer the first dose of 
measles vaccine in Pakistan is at 09th month of life and 
infants younger than 9 months infected with measles are 
missing the chance of being vaccinated. With the 
endemic situations and under 9 months measles incident 
of 30% as per recorded by the current study some 
immediate actions are required to deal with the situation.  
In this study, 30% of measles cases occurred in infants 
younger than 9 months of age. It is 10% lower than a 
previous study conducted in district Rawalpindi where 
40% of the admitted and diagnosed patients belonged to 
the 6 months age group.14 Also it is somewhat 
comparable to data from Bangladesh, where 31% of 
vaccinated and 17% of non-vaccinated infants younger 
than 9 months of age were affected by measles in a study 
documenting the incidence of this deadly disease in the 
under 9 months old age group.15 
This study showed that measles was more common in 
males as compared to females with a male to female ratio 
of 1.34%. This coincides with a study conducted in 
Thailand which also reported that males have a higher 
incidence of measles as compared to females.16This may 
be due to the fact that our society is male dominant 
society and male patients are brought to medical attention 
earlier than female patients. 
In current study, pneumonia and diarrhoea were the 
commonest complications and were present in 43.3% and 
44.2% cases respectively. A study done in a tertiary care 
hospital in Kolkata, West Bengal similarly showed 
pneumonia in 30.7% and diarrhoea in around 27% as the 
most frequent complications.17 Pneumonia occurred more 
in infants having measles with statistically significant 
difference. The reason for increased prevalence of 
pneumonia with measles is that measles virus causes a 
transient but profound immune suppression resulting in 
increased susceptibility to secondary bacterial and viral 
infections. Due to the development of these opportunistic 
infections, measles remains the leading vaccine-
preventable cause of child death worldwide.18,20. An 
earlier age of vaccination is proposed to be considered in 
epidemic or higher endemic situations. 
Conclusion 
Measles occurs in a significant number of younger infants 
in our setup and these infants can develop severe 
complications like pneumonia, diarrhoea, encephalitis, 
corneal ulceration etc. that can lead to significant 
morbidity and mortality.  
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